Stockreport

Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF Social Bond issuance underscores Royalty Pharma’s strong commitment to ESGSupports United Nations Sustainable Development Goals NEW YORK, July 15, 2021 (GLOBE NEWSWIR [Read more]